Africa’s cannabis economy is beginning to show signs of significant commercial acceleration, with growing investor confidence, expanding international participation and increasing regulatory engagement positioning the sector for long-term growth.
Global cannabis market estimates have climbed from roughly $21 billion in 2020 to more than $70 billion in recent years, as countries continue to formalise regulations and expand legal trade frameworks. Africa, particularly South Africa, is increasingly attracting attention as a strategic growth market within this evolving global landscape.
South Africa’s regulated cannabis market is already estimated to be worth more than R14 billion, with the broader market exceeding R30 billion when informal trade is included. Industry observers believe this reflects both strong existing demand and substantial growth potential as formalisation continues.
Momentum is also visible around The Cannabis Expo 2026, set to take place at the Sandton Convention Centre from 29–31 May. Organisers say the event has already recorded more than 30% growth in exhibitors and ticket sales compared to the previous year, highlighting rising commercial confidence and growing interest from investors and operators.
A major shift this year is the increase in international stakeholders exploring opportunities within Africa’s cannabis economy. Businesses are reportedly drawn by South Africa’s climate advantages, evolving legislation and export potential.
“The cannabis industry is no longer emerging, it is organising,” said Silas Howarth, Founder and CEO of The Cannabis Expo, describing the sector’s transition from fragmented activity into a more structured commercial environment.
The event will also include participation from institutions such as the South African Health Products Regulatory Authority (SAHPRA), the Department of Trade, Industry and Competition, Genesis Analytics and Trade & Industrial Policy Strategies, reflecting increasing engagement from regulators, policymakers and mainstream economic stakeholders.
Discussions at the expo are expected to focus on licensing delays, investment opportunities, medical cannabis access, export readiness, compliance risks and the long-term sustainability of cannabis businesses across the continent.
